Author: Dorron Blumberg

Baptist Health South Florida Offers Healthcare Practitioners Free Course On Prescribing Controlled Substances

Posted by | Oct 7, 2018 | |

Board-approved course meets new Florida relicensure requirement for allopathic and osteopathic physicians 
 
Baptist Health South Florida, the largest not-for-profit healthcare organization in South Florida, is now providing a free online course called Prescribing Controlled Substances, which meets Florida’s new, mandatory requirement for physician education on controlled substances. In an effort to reduce addiction and the number of deaths due to opioids and other controlled substances, the legislature passed The Controlled Substances Bill (HB 21) that requires all Florida healthcare practitioners registered with the U.S. Drug Enforcement Agency to prescribe controlled substances to complete a continuing education course by Jan. 31, 2019, and at each subsequent licensure renewal.
 

Read More

Scythian Biosciences Appoints Brady Cobb as CEO

Posted by | Oct 7, 2018 | |

Scythian Biosciences Corp. (the "Company" or “Scythian”) (CSE:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) announced today Brady Cobb, a leading voice in the medical cannabis industry, has been appointed Chief Executive Officer. Effective October 3, 2018, Mr. Cobb replaces Rob Reid, who has stepped down to focus on European Cannabis Investment opportunities and will remain as an active member of the Board of Directors and key person in driving the company’s strategic direction.

Read More

Fall Stroke Symposium

Posted by | Oct 4, 2018 | |

Presented by Holy Cross Hospital, the 2018 Fall Stroke Symposium will offer an educational and networking forum for attendees to hear from experts and learn more about stroke risks and treatments. The program is designed for...

Read More

South Florida Health Forum

Posted by | Oct 3, 2018 | |

Broad and Cassel presents the South Florida Health Forum on Wednesday, October 3 from 11 am to 6 pm at the Signature Grand, 6900 State Road 84, Davie. To register or for more information, contact Amanda Miller at (407) 839-4275...

Read More

MRI-Guided Radiation Therapy Aims to Prolong Survival and Reduce Complications for the Most Challenging Cancers

Posted by | Oct 2, 2018 | |

 Leading Radiation Oncology Experts Convene to Discuss Future of Radiation Therapy

 
Leading oncology experts from around the world met to discuss the integration of magnetic resonance imaging (MRI) with radiation therapy and its potential to extend life expectancy and reduce common side effects in many cancer patients. ViewRay, Inc. (NASDAQ: VRAY), maker of MRIdian®, the world’s first and only FDA-cleared, MRI-guided radiation therapy system, and Miami Cancer Institute, co-hosted experts from research hospitals at the cutting-edge of cancer treatment at the September 28 symposium and panel discussion

Read More